register

News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, named Vantive.

The groundwork for Vantive was laid in 2023 when Baxter announced its plans to carve out a standalone Kidney Care entity from its Renal Care and Acute Therapies divisions. The transition to the Vantive branding is slated to coincide with the separation, anticipated in the latter half of 2024, through either a divestiture to a private equity investor or a spinoff into a publicly traded entity.

Focused on delivering critical organ therapies for both acute and chronic kidney care, Vantive pledges to drive its team members towards fervently developing solutions tailored to the needs of clinicians and patients alike. This overarching purpose of ‘Extending Lives, Expanding Possibilities’ underscores the commitment to shaping an enhanced healthcare journey.

The emblem of Vantive showcases a distinctive “V” motif, partitioned into three segments, symbolising the innovative therapies, digital solutions, and advanced services the company is poised to offer. Rendered in a plum hue, the logo strategically combines the ‘stability and trustworthiness’ of Baxter’s primary brand colour, blue, with the ‘energy and boldness’ of red.

Chris Toth, Executive Vice President and Group President of Kidney Care at Baxter, slated to assume the role of Chief Executive Officer at Vantive post-separation, remarked, “With the reveal of our mission and logo, we have reached another critical milestone in our journey to establish Vantive. From our legacy as a pioneer in kidney care to our position as a market leader in chronic and acute therapies, we maintain a unique vantage point to help fulfill the pivotal needs of today’s clinicians and patients.”

Vantive will inherit and uphold Baxter’s storied heritage spanning nearly seven decades, characterised by its contributions and leadership in kidney care and critical organ support therapies. As it ventures forward, the company remains steadfast in its commitment to serving as a trusted ally to healthcare providers and clinicians globally, with a focus on enhancing outcomes for the over one million patients it serves annually across more than 70 nations.

Until the proposed separation culminates, the Kidney Care business will persist under the banner of Baxter, ensuring continuity in operations.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the ONLY one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change.

The exclusive leadership and influencer podcasts and vodcasts add huge value to our breaking news coverage. The content on Health Industry Hub is copyright protected and should only be accessed under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Clinicians unveil Novartis and BMS practice-changing trial results

Clinicians unveil Novartis and BMS practice-changing trial results

Health Industry Hub | June 24, 2024 |

Pharma News: Australia, known for its alarming melanoma rates, witnesses one person diagnosed with the disease every 30 minutes, and […]

More


News & Trends - Pharmaceuticals

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Hearts4heart leads awareness week, amid progress in Boehringer Ingelheim and AstraZeneca therapies

Health Industry Hub | June 24, 2024 |

Pharma News: Heart failure is a significant health concern in Australia, affecting approximately half a million people, with over 67,000 […]

More


News & Trends - MedTech & Diagnostics

Cardiologists mark Australian first with Boston Scientific's intracoronary imaging system

Cardiologists mark Australian first with Boston Scientific’s intracoronary imaging system

Health Industry Hub | June 24, 2024 |

MedTech & Diagnostics News: Percutaneous coronary intervention (PCI) has faced substantial complications and failure rates, despite advances in medical devices […]

More


Leadership & Management

AbbVie New Zealand welcomes new leadership amid global moves

AbbVie New Zealand welcomes new leadership amid global moves

Health Industry Hub | June 24, 2024 |

Leadership & Management: In line with its global talent development plan, AbbVie has announced a significant change in leadership for […]

More


This content is copyright protected. Please subscribe to gain access.